World's Best Scientists 2026 revealed!
Timothy R D J Radstake

Timothy R D J Radstake

D-Index & Metrics

Immunology

D-Index
81
Citations
24694
World Ranking
1560
National Ranking
58

Timothy R D J Radstake publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Timothy R D J Radstake sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 375 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Timothy R D J Radstake D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Timothy R D J Radstake sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Timothy R D J Radstake is affiliated with Utrecht University in the Netherlands and has contributed extensively to medical research, particularly within the field of rheumatology. Their work spans a variety of subfields including immunology, genetics, pathology and forensic medicine, and molecular biology. The main focus of their research involves rheumatoid arthritis and related autoimmune and inflammatory disorders.

Radstake's publication record includes significant papers such as:

  • EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors, 2020, Annals of the Rheumatic Diseases
  • Multiomics and Machine Learning Accurately Predict Clinical Response to Adalimumab and Etanercept Therapy in Patients With Rheumatoid Arthritis, 2020, Arthritis & Rheumatology
  • Machine learning in rheumatology approaches the clinic, 2020, Nature Reviews Rheumatology
  • Immune checkpoint inhibitor-associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation, 2021, European Journal of Cancer
  • Efficacy and Safety of ABBV-3373, a Novel Anti-Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody-Drug Conjugate, in Adults with Moderate-to-Severe Rheumatoid Arthritis Despite Methotrexate Therapy: A Randomized, Double-Blind, Active-Controlled Proof-of-Concept Phase IIa Trial, 2022, Arthritis & Rheumatology

Frequent publication venues for Radstake's research include:

  • Annals of the Rheumatic Diseases
  • Arthritis & Rheumatology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Lara D. Veeken

Radstake has collaborated with several researchers, prominently including:

  • Aridaman Pandit
  • Weiyang Tao
  • Hendrik Schulze-Koops
  • Olivier Lambotte
  • Xavier Mariette

The scientist's main fields of study center on medicine and especially rheumatology, supported by subfields such as immunology and genetics. Their research addresses clinical challenges and mechanisms related to autoimmune conditions, with topics that cover:

  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Chronic Lymphocytic Leukemia Research
  • Autoimmune and Inflammatory Disorders Research
  • Systemic Sclerosis and Related Diseases
  • Spondyloarthritis Studies and Treatments
  • T-cell and B-cell Immunology

Best Publications

  • Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

    Eli A Stahl;Soumya Raychaudhuri;Soumya Raychaudhuri;Elaine F Remmers;Gang Xie

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Mübeccel Akdis

  • Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages

    E R Vossenaar;T R D Radstake;A van der Heijden;M A M van Mansum

  • Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis

    Shahla Abdollahi-Roodsaz;Leo A.B. Joosten;Marije I. Koenders;Isabel Devesa

  • Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells.

    Charles Antoine Dutertre;Charles Antoine Dutertre;Etienne Becht;Sergio Erdal Irac;Sergio Erdal Irac;Ahad Khalilnezhad;Ahad Khalilnezhad

  • Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

    L. Van Bon;L. Van Bon;A. J. Affandi;A. J. Affandi;J. Broen;J. Broen;R. B. Christmann

  • Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis

    T.R.D.J. Radstake;M. Svenson;A.M.M. Eijsbouts;F.H.J. van den Hoogen

  • Systematic validation of specific phenotypic markers for in vitro polarized human macrophages.

    C.A. Ambarus;S. Krausz;M. van der Eijk;J. Hamann

  • Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

    Timothy R.D.J. Radstake;Olga Y Gorlova;Blanca Rueda;Jose Ezequiel Martin

  • Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci

    Alexandra Zhernakova;Alexandra Zhernakova;Alexandra Zhernakova;Eli A. Stahl;Eli A. Stahl;Gosia Trynka;Soumya Raychaudhuri

  • Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.

    Timothy R D J Radstake;Mieke F Roelofs;Yvonne M Jenniskens;Birgitte Oppers-Walgreen

  • IL-32, a proinflammatory cytokine in rheumatoid arthritis.

    Leo A. B. Joosten;Mihai G. Netea;Soo-Hyun Kim;Do-Young Yoon

  • Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis.

    Shahla Abdollahi-Roodsaz;Leo A. B. Joosten;Mieke F. Roelofs;Timothy R. D. J. Radstake

  • Identification of Small Heat Shock Protein B8 (HSP22) as a Novel TLR4 Ligand and Potential Involvement in the Pathogenesis of Rheumatoid Arthritis

    Mieke F. Roelofs;Wilbert C. Boelens;Leo A. B. Joosten;Shahla Abdollahi-Roodsaz

  • Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis.

    C Popa;M G Netea;T Radstake;J W M Van der Meer

  • Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma.

    Swati Bhattacharyya;Kathleen Kelley;Denisa S. Melichian;Zenshiro Tamaki

  • Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases.

    Alexandra Zhernakova;Behrooz Z. Alizadeh;Behrooz Z. Alizadeh;Marianna Bevova;Miek A. van Leeuwen

  • Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.

    Timothy R. D. J. Radstake;Fred C. G. J. Sweep;Paco Welsing;Barbara Franke

  • EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.

    Marie Kostine;Axel Finckh;Clifton O. Bingham;Karen Visser

  • The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGFβ and IFNγ Distinguishes SSc Phenotypes

    Timothy R. D. J. Radstake;Timothy R. D. J. Radstake;Lenny van Bon;Lenny van Bon;Jasper Broen;Jasper Broen;Anila Hussiani

  • Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy

    Olga Gorlova;Jose Ezequiel Martin;Blanca Rueda;Bobby P C Koeleman

Frequent Co-Authors

Joel A G van Roon
Joel A G van Roon University Medical Center Utrecht
Bobby P.C. Koeleman
Bobby P.C. Koeleman Utrecht University
Jane Worthington
Jane Worthington University of Manchester
Ariane L. Herrick
Ariane L. Herrick University of Manchester
Torsten Witte
Torsten Witte Hannover Medical School
Pilar Barrera
Pilar Barrera Radboud University Nijmegen Medical Centre
Christopher P. Denton
Christopher P. Denton University College London
Javier Martín
Javier Martín Spanish National Research Council
Wim B. van den Berg
Wim B. van den Berg Radboud University
Maureen D. Mayes
Maureen D. Mayes The University of Texas at Austin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related online degrees can open numerous career pathways in healthcare and research. Many students consider programs that offer quicker routes into clinical roles, such as nursing. Programs highlighted in easiest accelerated nursing programs to get into provide an opportunity to transition swiftly into patient care roles, which can complement immunology expertise.

Additionally, if you’re aiming for entry-level nursing credentials, looking into the easy LPN programs to get into offers practical pathways to work alongside immunologists in clinical environments. These programs are designed to balance accessibility with quality training.

For those targeting advanced practice roles, understanding what is the easiest NP program can help identify programs that provide a streamlined path to becoming a nurse practitioner, often involving immunology-related specialties.

Moreover, specialized areas such as psychiatric mental health nurse practitioner roles are critical in holistic patient care. The best PMHNP programs emphasize strong clinical placements, preparing graduates for impactful careers that intersect with immunological health and wellness.

Best Scientists Citing Timothy R D J Radstake

Trending Scientists

Recently Published Articles